CVS Health Co. (NYSE:CVS) Receives Average Rating of “Moderate Buy” from Analysts

Shares of CVS Health Co. (NYSE:CVS) have been given an average recommendation of “Moderate Buy” by the nineteen analysts that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $69.12.

A number of equities research analysts have recently issued reports on CVS shares. Truist Financial reissued a “buy” rating and set a $67.00 price objective (down previously from $76.00) on shares of CVS Health in a research report on Wednesday, November 20th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Mizuho cut their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Piper Sandler decreased their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Finally, UBS Group increased their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th.

Institutional Investors Weigh In On CVS Health

Several large investors have recently bought and sold shares of CVS. Garland Capital Management Inc. grew its stake in shares of CVS Health by 0.3% in the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock worth $3,591,000 after buying an additional 160 shares in the last quarter. Sound Income Strategies LLC grew its position in CVS Health by 7.2% in the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator’s stock worth $151,000 after acquiring an additional 162 shares in the last quarter. Hexagon Capital Partners LLC raised its position in CVS Health by 3.5% during the third quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator’s stock valued at $331,000 after purchasing an additional 178 shares during the period. Bruce G. Allen Investments LLC lifted its stake in shares of CVS Health by 13.1% in the 3rd quarter. Bruce G. Allen Investments LLC now owns 1,681 shares of the pharmacy operator’s stock valued at $106,000 after purchasing an additional 195 shares during the last quarter. Finally, HHM Wealth Advisors LLC increased its position in shares of CVS Health by 11.9% during the 2nd quarter. HHM Wealth Advisors LLC now owns 1,886 shares of the pharmacy operator’s stock valued at $111,000 after purchasing an additional 200 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 1.0 %

CVS Health stock opened at $44.49 on Wednesday. The stock has a market cap of $55.99 billion, a PE ratio of 11.29, a price-to-earnings-growth ratio of 0.85 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a fifty day moving average of $54.13 and a 200 day moving average of $57.64. CVS Health has a one year low of $43.56 and a one year high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.21 EPS. As a group, sell-side analysts predict that CVS Health will post 5.32 EPS for the current year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.